China Health Holding, Inc. (OTC: CHHH) is a development stage company focused on becoming a leading developer, manufacturer, marketer and distributor of pharmaceutical drugs and dietary supplements in China and worldwide.
The company has recently executed a definitive agreement for the acquisition of a majority stake in Beijing Boran Pharmaceutical Co. Ltd.
The terms of agreement include:
- China Health will acquire 65% of the total issued and outstanding capital stock of Beijing Boran, giving it control over various Beijing Boran assets.
- China Health will pay Beijing Boran shareholders $3 million in cash at closing.
Established in 2002, Beijing Boran Pharmaceutical Co. Ltd. is private pharmaceutical company in Beijing, People's Republic of China, engaged in the businesses of developing, manufacturing and marketing various herbal-based pharmaceuticals drugs.
Find more details of the acquisition agreement from the press release.
Comment Preview